ID
45648
Beskrivning
Principal Investigator: Ghislaine Scélo, PhD, International Agency for Research on Cancer (IARC), Lyon, France MeSH: Carcinoma, Renal Cell,Kidney Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001271 Incidence rates of renal cell carcinoma (RCC) are rising and the latest estimates show that it accounts for over 300,000 cases and 120,000 deaths worldwide each year. Mechanisms underlying RCC occurrence are not fully understood and a large part of the disease heritability remains unexplained. The study aimed at augmenting the size of available RCC genome-wide association studies to increase the statistical power to detect genetic variants associated with the disease. The study includes genome-wide genotyping data from RCC cases (n=2,781) and controls (n=2,526) recruited in Western Europe, Central and Eastern Europe, and Australia.
Länk
Nyckelord
Versioner (1)
- 2023-03-20 2023-03-20 - Simon Heim
Rättsinnehavare
Ghislaine Scélo, PhD, International Agency for Research on Cancer (IARC), Lyon, France
Uppladdad den
20 mars 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001271 Pooled Genome-Wide Analysis of Kidney Cancer Risk (KIDRISK)
This sample attributes table contains sample IDs, body site, analyte type, DNA sample whole-genome amplified, tumor status, and name of the center which conducted genotyping.
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject source, and case control status of the subject for kidney cancer.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age, sex, and study code.
- This sample attributes table contains sample IDs, body site, analyte type, DNA sample whole-genome amplified, tumor status, and name of the center which conducted genotyping.
Similar models
This sample attributes table contains sample IDs, body site, analyte type, DNA sample whole-genome amplified, tumor status, and name of the center which conducted genotyping.
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject source, and case control status of the subject for kidney cancer.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age, sex, and study code.
- This sample attributes table contains sample IDs, body site, analyte type, DNA sample whole-genome amplified, tumor status, and name of the center which conducted genotyping.
C2348585 (UMLS CUI [1,2])
C1520146 (UMLS CUI [1,2])
C0027651 (UMLS CUI [1,2])
C5575037 (UMLS CUI [1,2])
C1285573 (UMLS CUI [1,3])